Xiao X. Wei
Impact in
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Prostate Cancer Treatment and Research 33
- Renal cell carcinoma treatment 7
- Oncology 26
- Cancer Immunotherapy and Biomarkers 19
- CAR-T cell therapy research 3
- Co-authors
- Bradley Alexander McGregor (16 shared papers)Toni K. Choueiri (11 shared papers)Markus Essler (6 shared papers)Hojjat Ahmadzadehfar (6 shared papers)Lauren C. Harshman (10 shared papers)Lawrence H. Fong (8 shared papers)Eric Jay Small (6 shared papers)Charles J. Ryan (7 shared papers)
- Journals
- Annals of Oncology (5 papers)Cancer Immunology Research (4 papers)Journal of Clinical Oncology (4 papers)European Urology Oncology (3 papers)Journal of Nuclear Medicine (3 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Xiao X. Wei
72 papers receiving 2.6k citations
Xiao X. Wei's Hit Papers
Peers
Comparison fields: 5 of 90
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 856
- Cancer Research 403
- Radiology, Nuclear Medicine and Imaging 436
- Immunology 266
Countries citing papers authored by Xiao X. Wei
This map shows the geographic impact of Xiao X. Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao X. Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao X. Wei more than expected).
Fields of papers citing papers by Xiao X. Wei
This network shows the impact of papers produced by Xiao X. Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao X. Wei. The network helps show where Xiao X. Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao X. Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial Hit paper breakdown → | 2024 | 176 |
| 2 | 2017 | 142 | |
| 3 | 2021 | 130 | |
| 4 | 2019 | 116 | |
| 5 | 2019 | 112 | |
| 6 | 2018 | 107 | |
| 7 | 2018 | 105 | |
| 8 | Evolution of myeloid-mediated immunotherapy resistance in prostate cancer Hit paper breakdown → | 2024 | 96 |
| 9 | 2018 | 94 | |
| 10 | 2010 | 85 | |
| 11 | 2020 | 80 | |
| 12 | 2019 | 79 | |
| 13 | 2006 | 75 | |
| 14 | 2023 | 74 | |
| 15 | 2023 | 72 | |
| 16 | 2020 | 71 | |
| 17 | 2005 | 66 | |
| 18 | 2019 | 66 | |
| 19 | 2024 | 65 | |
| 20 | 2017 | 60 |
About Xiao X. Wei
Xiao X. Wei is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 77 papers that have together received 2.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (33 papers), Cancer Immunotherapy and Biomarkers (19 papers), Radiopharmaceutical Chemistry and Applications (11 papers), Bladder and Urothelial Cancer Treatments (10 papers), Immunotherapy and Immune Responses (9 papers), Renal cell carcinoma treatment (7 papers), Cancer Genomics and Diagnostics (5 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Oncology (856 citations), Cancer Research (403 citations), Radiology, Nuclear Medicine and Imaging (436 citations) and Immunology (266 citations). Xiao X. Wei has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Bradley Alexander McGregor, Toni K. Choueiri, Markus Essler, Hojjat Ahmadzadehfar, Lauren C. Harshman, Lawrence H. Fong, Eric Jay Small, Charles J. Ryan, Stefan Kürpig and Anna Yordanova. Their work appears in journals such as Annals of Oncology, Cancer Immunology Research, Journal of Clinical Oncology, European Urology Oncology and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.